Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
B-12 Blends The Bounce Back When life knocks you down & you need a powerful boost of energy, recovery, repair & regeneration to get back into your best, this is it
BPC 157s effect on healing, Journal of Physiology-Paris, Volume 91, Issues 35, MayOctober 1997, Pages 173-178 (5) Xue XC, Wu YJ, Gao MT, Li WG, Zhao N, Wang ZL, Bao CJ, Yan Z, Zhang YQ
Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment
Quick recovery with no lengthy breaks from daily activities